United Therapeutics Corporation (UTHR)
After hours:
| Previous Close | 258.13 |
| Open | 260.33 |
| Bid | 262.27 x 100 |
| Ask | 262.54 x 100 |
| Day's Range | 255.93 - 262.51 |
| 52 Week Range | 204.44 - 262.51 |
| Volume | |
| Avg. Volume | 511,773 |
| Market Cap | 11.642B |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | 12.42 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
30 Most Profitable Companies with Highest Margins in the World
In this article, we will be taking a look at the 30 Most Profitable Companies with Highest Margins in the World. To learn about other Most Profitable Companies with Highest Margins in the World, you can go directly to the 5 Most Profitable Companies with Highest Margins in the World. In today’s competitive global marketplace, […]
- Zacks
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
United Therapeutics' (UTHR) first-quarter 2024 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.
- Insider Monkey
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript May 1, 2024 United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.17, expectations were $5.65. UTHR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the […]
